TrialPloS one2021

Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial.

Patricia M LoRusso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.